| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-545 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D219-12 |
| filingDate |
2015-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2017-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2017509635-A |
| titleOfInvention |
Design, synthesis and biological activity of platinum-benzo [c] acridine hybrid drugs and related methods |
| abstract |
The present invention relates to compounds of formula (I), pharmaceutically acceptable salts thereof, and solvates. [Chemical 1] In which the various substituents are as defined herein. Compounds of formula (I), solvates and salts thereof are effective as anticancer compounds. [Selection] Figure 1 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102415376-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11588111-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11563183-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190015681-A |
| priorityDate |
2014-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |